CellCept - Mycophenolate - Dosage - Side Effects - Drug Interactions
CellCept (mycophenolate mofetil) drug information, dosage, side effects, drug interactions, and warnings. CellCept, generic name mycophenolate mofetil, is an immunosuppressive used to manage organ transplants. CellCept is also a DMARD (disease-modifying anti-rheumatic drug) used to treat arthritis, lupus, and other autoimmune disorders.
Drugs A-Z - CellCept / Mycophenolate Tablets Or Capsules
Patient education for CellCept / mycophenolate tablets or capsules.
Patient education for CellCept / mycophenolate tablets or capsules.
The Facts Of DMARDs
Learn about disease-modifying anti-rheumatic drugs such as methotrexate and gold.
Learn about disease-modifying anti-rheumatic drugs such as methotrexate and gold.
Side Effects - Mycophenolate (CellCept)
The common side effects of mycophenolate (CellCept).
The common side effects of mycophenolate (CellCept).
ACR Patient Education: Mycophenolate (Cellcept)
Mycophenolate (Cellcept) belongs to a class of medications known as immunosuppressives. Mycophenolate has been used to treat people with lupus (especially those with symptoms of kidney disease), rheumatoid arthritis, vasculitis, inflammatory bowel disease such as Crohn's disease, and some other kidney or skin disorders, from ACR.
Mycophenolate (Cellcept) belongs to a class of medications known as immunosuppressives. Mycophenolate has been used to treat people with lupus (especially those with symptoms of kidney disease), rheumatoid arthritis, vasculitis, inflammatory bowel disease such as Crohn's disease, and some other kidney or skin disorders, from ACR.
Patient Information: CellCept (mycophenolate mofetil capsules)
Information on CellCept(mycophenolate mofetil capsules), from Hoffmann-La Roche.
Information on CellCept(mycophenolate mofetil capsules), from Hoffmann-La Roche.
Drug Profile: CellCept (Mycophenolate Mofetil)
Drug Profile and essential information for CellCept (Mycophenolate Mofetil), from UMM.
Drug Profile and essential information for CellCept (Mycophenolate Mofetil), from UMM.
FDA Warning for CellCept 8/2009
Roche notified healthcare professionals that cases of Pure Red Cell Aplasia (PRCA) have been reported in patients treated with CellCept.
Roche notified healthcare professionals that cases of Pure Red Cell Aplasia (PRCA) have been reported in patients treated with CellCept.